APRILIOS
Live / Applied — Third extension granted (statement of use) (as of 19 Sept 2025)
What this means for you
Not registered yet, but its 06 Apr 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97350614
- Mark type
- Stylized text
- Filed
- 06 Apr 2022
- Published for opposition
- 12 Dec 2023
- Attorney of record
- Jayme M. Torelli
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and medicinal preparations for the treatment, prevention, or amelioration of symptoms of gastroparesis or motion sickness; pharmaceutical and medicinal preparations for the treatment or prevention of nausea or vomiting; all the aforementioned goods containing tradipitant, all being in capsule form for oral administration, and all being available only by prescription; pharmaceutical products for the treatment, prevention, or amelioration of symptoms of gastroparesis or motion sickness; pharmaceutical products for the treatment or prevention of nausea or vomiting; all containing tradipitant; all the aforementioned goods being in capsule form for oral administration, and all being available only by prescription
Owner
- Vanda Pharmaceuticals Inc., Washington, DC, US
- Vanda Pharmaceuticals Inc., Washington, DC, US
Prosecution history
- 20 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Sept 2025 — SOU EXTENSION 3 GRANTED
- 19 Sept 2025 — SOU EXTENSION 3 FILED
- 19 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 03 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 May 2025 — SOU EXTENSION 2 GRANTED
- 02 May 2025 — SOU EXTENSION 2 FILED
- 02 May 2025 — SOU TEAS EXTENSION RECEIVED
- 01 Nov 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Nov 2024 — SOU EXTENSION 1 GRANTED
- 01 Nov 2024 — SOU EXTENSION 1 FILED
- 01 Nov 2024 — SOU TEAS EXTENSION RECEIVED
- 04 Jun 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 21 Apr 2024 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 08 Jan 2024 — EXTENSION OF TIME TO OPPOSE RECEIVED